Credit: Mattpopovich / CC0 / Wikimedia Commons The division of people into various social classes is a persistent feature across civilizations and was no less the case in ancient Greece where social ...

How do you explain one Zantac manufacturer kiboshing a favorable trend of defense verdicts and decisions – with a massive $2.2 billion settlement? The answer appears to lie with the whistleblower suit ...

Here are several reasons why hiring a Zantac lawsuit lawyer is critical: While many individuals have filed individual lawsuits, there are also class action lawsuits involving Zantac. A class action ...

Please note that classification priorities can change quickly, and the expected dates of completion are only indicative at the time of publication. There is high demand for classification assessments, ...

What is the NOVA method of food classification? Food processing ensures safety and shelf life by transforming raw components into new products. In the last several decades, this has changed in ...

The Mercedes-Benz E-Class has a long, storied history with India with the first model officially launched almost 30 years ago. It has been going strong ever since and has been the bestselling ...

When you put 100 chefs in a room, things are bound to get heated. The Korean reality show Culinary Class Wars is a high-stakes series that brings together culinary professionals with backgrounds ...

The UK based drug firm GSK has agreed to pay up to $2.2bn (£1.7bn; €2bn) to settle claims that the heartburn drug ranitidine (previously marketed in the US as Zantac) caused cancer. The deal, ...

GSK agreed to pay $2.2 billion to settle approximately 80,000 lawsuits in U.S. courts over claims its heartburn drug, Zantac, caused cancer. The settlements account for 93% of all cases and were ...

GSK has struck a $2.2 billion agreement to settle the vast majority of U.S. lawsuits filed against it over claims its Zantac heartburn remedy causes cancer. The British drugmaker’s settlement ...

Zantac, first sold in the US in 1983, was one of the best-selling medicines globally, bringing in more than $1bn (€0.91bn) in sales per year. It was also sold by Sanofi, a French drug company ...